全文获取类型
收费全文 | 358909篇 |
免费 | 13543篇 |
国内免费 | 720篇 |
专业分类
耳鼻咽喉 | 3731篇 |
儿科学 | 11723篇 |
妇产科学 | 6564篇 |
基础医学 | 40700篇 |
口腔科学 | 5181篇 |
临床医学 | 30634篇 |
内科学 | 69681篇 |
皮肤病学 | 3541篇 |
神经病学 | 34812篇 |
特种医学 | 15199篇 |
外国民族医学 | 13篇 |
外科学 | 55858篇 |
综合类 | 5026篇 |
现状与发展 | 3篇 |
一般理论 | 210篇 |
预防医学 | 31969篇 |
眼科学 | 7592篇 |
药学 | 21415篇 |
中国医学 | 830篇 |
肿瘤学 | 28490篇 |
出版年
2023年 | 745篇 |
2022年 | 1282篇 |
2021年 | 2973篇 |
2020年 | 1861篇 |
2019年 | 3034篇 |
2018年 | 25044篇 |
2017年 | 19538篇 |
2016年 | 22027篇 |
2015年 | 4458篇 |
2014年 | 6078篇 |
2013年 | 8902篇 |
2012年 | 18535篇 |
2011年 | 33057篇 |
2010年 | 25289篇 |
2009年 | 17750篇 |
2008年 | 30860篇 |
2007年 | 33857篇 |
2006年 | 12720篇 |
2005年 | 14614篇 |
2004年 | 15156篇 |
2003年 | 15561篇 |
2002年 | 13386篇 |
2001年 | 2124篇 |
2000年 | 1884篇 |
1999年 | 2082篇 |
1998年 | 2669篇 |
1997年 | 2337篇 |
1996年 | 1882篇 |
1995年 | 1768篇 |
1994年 | 1618篇 |
1993年 | 1525篇 |
1992年 | 1347篇 |
1991年 | 1265篇 |
1990年 | 1179篇 |
1989年 | 1129篇 |
1988年 | 1077篇 |
1987年 | 952篇 |
1986年 | 1026篇 |
1985年 | 1127篇 |
1984年 | 1377篇 |
1983年 | 1324篇 |
1982年 | 1748篇 |
1981年 | 1573篇 |
1980年 | 1521篇 |
1979年 | 901篇 |
1978年 | 1006篇 |
1977年 | 891篇 |
1976年 | 807篇 |
1975年 | 642篇 |
1974年 | 708篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
B. A. Johnson Donald R. Jasinski Gantt P. Galloway Henry Kranzler Robert Weinreib Raymond F. Anton Barbara J. Mason Michael J. Bohn Helen M. Pettinati Richard Rawson Christopher Clyde 《Psychopharmacology》1996,128(2):206-215
Four hundred and twenty-three alcohol dependent subjects were enrolled into a 12-week randomized, double-blind, placebo-controlled
study to determine the safety and efficacy of the 5-HT2 receptor antagonist, ritanserin (2.5 mg/day or 5 mg/day), in reducing alcohol intake and craving. All subjects received 1
week of single-blind placebo prior to randomization into the 11-week double-blind phase. Additionally, all subjects received
weekly individual sessions of manual-guided cognitive-behavioral therapy. Comparing the single-blind period with endpoint,
there was approximately a 23% reduction in drinks/day; 34% fall in the total number of drinking days/week; 22% decrease in
drinks/drinking day; and a 37% diminution in alcohol craving for all treatment groups. All treatment groups experienced a
beneficial clinical outcome as assessed by the Clinical Global Impression Scale. There was, however, no significant difference
between treatment groups on any of these measures of alcohol drinking, craving, or clinical outcome. Subjects were of relatively
high social functioning at baseline, and this did not change significantly during treatment. Treatment groups did not differ
significantly on either medication compliance or reported adverse events. Ritanserin treatment was associated with a dose-related
prolongation of subjects’ QTc interval recording on the electrocardiogram. These results suggest that alcohol dependent subjects
can show marked clinical improvement within a structured alcohol treatment program. These findings do not support an important
role for ritanserin in the treatment of alcohol dependence.
Received: 30 April 1996/Final version: 3 July 1996 相似文献
92.
93.
94.
Herbert Radner Yosuf El-Shabrawi Robert H. Eibl Oliver Brüstle Lukas Kenner Paul Kleihues Otmar D. Wiestler 《Acta neuropathologica》1993,86(5):456-465
Introduction into fetal rat brain cells of a replication-defective retroviral vector harboring v-Ha-ras and v-gag-myc rapidly causes the induction of highly malignant undifferentiated neuroectodermal tumors following transplantation into the brains of syngeneic hosts [Wiestler, et al. (1992) Cancer Res. 52: 3760–3767]. In the present study, we have investigated the modulating effect of the developmental stage of neural target cells and of the dose of the retroviral vector used in the grafting experiments. Exposure of fetal cells from embryonic day (E)12 or E14 produced a 100% incidence of malignant neuroectodermal tumors which led to the death of recipient animals after a median latency period of 32 days. A 100-fold reduction of the virus dose from 2.062×106 to 2.062×104 focus-forming units/ml resulted in a lower tumor incidence of 25%. Of six neural grafts exposed to v-Ha-ras and v-myc at E16, only one showed evidence of tumorigenesis (low-grade astrocytoma and hemangioma). All other transplants were morphologically normal for observation periods of 26 weeks, indicating a marked loss of transforming activity of ras and myc in more advanced stages of brain development. In retrovirus-exposed donor cells which caused the development of neural tumors in recipient rats, malignant transformation was also evident during culture in vitro, usually after 9–12 days. Oncogene complementation was also studied in the newborn rat brain. After microinjection of the retroviral vector into the brain at postnatal day (P)0, P1 and P3, 5 out of 20 animals (25%) developed a total of seven brain tumors. Histopathologically, three of these neoplasms were malignant neuroectodermal tumors which, in contrast to those induced in fetal brain transplants showed evidence of focal glial and/or neuronal differentiation. In addition, we observed one oligodendroglioma, two hemangiomas and a malignant hemangioendothelioma. These data indicate that neural precursor cells and endothelia of the rat brain represent the major target cells for the complementary action of ras and myc and that the use of target cells from later developmental stages (E16 and postnatal) leads to the induction of both primitive and more differentiated neoplasms.These studies were supported by the Fonds zur Förderung der wissenschaftlichen Forschung in Österreich (Erwin Schrödinger fellowship, JO501-MED), by the Swiss National Science Foundation and by the Cancer League of the Kanton of Zürich 相似文献
95.
Data on 232 members of a single pedigree, descended from two pairs of original parents, were made available to the participants of Genetic Analysis Workshop 8 (GAW8). In addition to information concerning age and sex, measurements for 10 quantitative traits and genotypes at 22 polymorphic marker loci were also provided for a subset of 193 of these family members. © 1993 Wiley-Liss, Inc. 相似文献
96.
Irwin L. Flink 《Brain structure & function》2002,205(3):235-244
97.
98.
99.
100.